Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer

M Ruscetti, JP Morris, R Mezzadra, J Russell, J Leibold… - Cell, 2021 - cell.com
M Ruscetti, JP Morris, R Mezzadra, J Russell, J Leibold, PB Romesser, J Simon, A Kulick
Cell, 2021cell.com
(Cell 181, 424–441. e1–e21; April 16, 2020) In the original article, we reported that
senescence-inducing therapies can induce vascular remodeling that sensitizes pancreas
cancers to chemo-and immunotherapies. We recently realized that we omitted some data
that should have been included in the paper. This happened because we inadvertently
failed to update four figure panels with some of the final study data that we collected, and for
part of Figure S7, we inadvertently included data from S7D in S7F. We describe the errors …
(Cell 181, 424–441. e1–e21; April 16, 2020) In the original article, we reported that senescence-inducing therapies can induce vascular remodeling that sensitizes pancreas cancers to chemo-and immunotherapies. We recently realized that we omitted some data that should have been included in the paper. This happened because we inadvertently failed to update four figure panels with some of the final study data that we collected, and for part of Figure S7, we inadvertently included data from S7D in S7F. We describe the errors below, and we are including updated versions of Figures 3F, 6A, S5B, and S7F. The errors do not alter the conclusions drawn from the figures.
cell.com